Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 5.14454581 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 5.14454581 |
3 | sarcomere organization (GO:0045214) | 4.58546624 |
4 | thyroid hormone generation (GO:0006590) | 4.10418264 |
5 | tricarboxylic acid cycle (GO:0006099) | 4.06255138 |
6 | nucleobase catabolic process (GO:0046113) | 4.05326934 |
7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.72556465 |
8 | cardiac myofibril assembly (GO:0055003) | 3.71699723 |
9 | detection of calcium ion (GO:0005513) | 3.70341488 |
10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.66149365 |
11 | NADH metabolic process (GO:0006734) | 3.62961885 |
12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.61684178 |
13 | glycine transport (GO:0015816) | 3.61395867 |
14 | peptide hormone processing (GO:0016486) | 3.57832735 |
15 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.55631731 |
16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.48008858 |
17 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.47248644 |
18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.39345724 |
19 | plasma membrane repair (GO:0001778) | 3.38996218 |
20 | thyroid hormone metabolic process (GO:0042403) | 3.38668759 |
21 | regulation of membrane repolarization (GO:0060306) | 3.36489148 |
22 | myofibril assembly (GO:0030239) | 3.34878050 |
23 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.31999539 |
24 | response to parathyroid hormone (GO:0071107) | 3.22069762 |
25 | positive regulation of insulin secretion (GO:0032024) | 3.21646080 |
26 | carnitine shuttle (GO:0006853) | 3.20688101 |
27 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.15396518 |
28 | growth hormone secretion (GO:0030252) | 3.15109620 |
29 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.14157846 |
30 | cardiac muscle contraction (GO:0060048) | 3.13704512 |
31 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.13605323 |
32 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.08632779 |
33 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.08562030 |
34 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.06285972 |
35 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.05656067 |
36 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.99902756 |
37 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.99168007 |
38 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.99000139 |
39 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.97039966 |
40 | positive regulation of vesicle fusion (GO:0031340) | 2.95957391 |
41 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.94720566 |
42 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.93104342 |
43 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.91947586 |
44 | synaptic vesicle maturation (GO:0016188) | 2.91459537 |
45 | gamma-aminobutyric acid transport (GO:0015812) | 2.91343541 |
46 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.91289038 |
47 | nitric oxide mediated signal transduction (GO:0007263) | 2.89736895 |
48 | muscle filament sliding (GO:0030049) | 2.87980780 |
49 | actin-myosin filament sliding (GO:0033275) | 2.87980780 |
50 | heart trabecula formation (GO:0060347) | 2.86822818 |
51 | endocrine pancreas development (GO:0031018) | 2.86264573 |
52 | oxaloacetate metabolic process (GO:0006107) | 2.86127427 |
53 | regulation of cell communication by electrical coupling (GO:0010649) | 2.84507665 |
54 | positive regulation of glycolytic process (GO:0045821) | 2.83477725 |
55 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.83233440 |
56 | cell communication by electrical coupling (GO:0010644) | 2.82449724 |
57 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.81628461 |
58 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.81613408 |
59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.81001585 |
60 | membrane repolarization during action potential (GO:0086011) | 2.80583383 |
61 | cell communication involved in cardiac conduction (GO:0086065) | 2.80494566 |
62 | positive regulation of amino acid transport (GO:0051957) | 2.79256375 |
63 | protein retention in ER lumen (GO:0006621) | 2.78432243 |
64 | actomyosin structure organization (GO:0031032) | 2.78074539 |
65 | regulation of insulin secretion (GO:0050796) | 2.77924058 |
66 | glutamate secretion (GO:0014047) | 2.77910844 |
67 | toxin metabolic process (GO:0009404) | 2.76347287 |
68 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.74162338 |
69 | response to dietary excess (GO:0002021) | 2.74107813 |
70 | succinate metabolic process (GO:0006105) | 2.73140878 |
71 | activation of protein kinase A activity (GO:0034199) | 2.72349862 |
72 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.70873912 |
73 | cardiac conduction (GO:0061337) | 2.70026040 |
74 | fatty acid transmembrane transport (GO:1902001) | 2.69729099 |
75 | regulation of actin filament-based movement (GO:1903115) | 2.66913929 |
76 | cellular response to glucagon stimulus (GO:0071377) | 2.66625472 |
77 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.66173738 |
78 | ATP synthesis coupled proton transport (GO:0015986) | 2.66173738 |
79 | insulin secretion (GO:0030073) | 2.64188874 |
80 | neurotransmitter secretion (GO:0007269) | 2.63821991 |
81 | COPII vesicle coating (GO:0048208) | 2.62739419 |
82 | regulation of skeletal muscle contraction (GO:0014819) | 2.61916501 |
83 | respiratory electron transport chain (GO:0022904) | 2.60647700 |
84 | positive regulation of peptide hormone secretion (GO:0090277) | 2.60090574 |
85 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.57743678 |
86 | electron transport chain (GO:0022900) | 2.56928303 |
87 | regulation of hexokinase activity (GO:1903299) | 2.56461248 |
88 | regulation of glucokinase activity (GO:0033131) | 2.56461248 |
89 | striated muscle contraction (GO:0006941) | 2.56432769 |
90 | regulation of sarcomere organization (GO:0060297) | 2.55096887 |
91 | regulation of cofactor metabolic process (GO:0051193) | 2.54452535 |
92 | regulation of coenzyme metabolic process (GO:0051196) | 2.54452535 |
93 | dendritic spine morphogenesis (GO:0060997) | 2.53333487 |
94 | positive regulation of peptide secretion (GO:0002793) | 2.53202391 |
95 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.52706711 |
96 | tricarboxylic acid metabolic process (GO:0072350) | 2.52262615 |
97 | auditory receptor cell differentiation (GO:0042491) | 2.51259697 |
98 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.51169782 |
99 | macroautophagy (GO:0016236) | 2.50605955 |
100 | regulation of peptide hormone secretion (GO:0090276) | 2.50182994 |
101 | negative regulation of JUN kinase activity (GO:0043508) | 2.49632100 |
102 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.49545021 |
103 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.49449698 |
104 | regulation of heart rate (GO:0002027) | 2.48695409 |
105 | regulation of synapse structural plasticity (GO:0051823) | 2.48362675 |
106 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.48260688 |
107 | regulation of relaxation of muscle (GO:1901077) | 2.47868969 |
108 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.47779982 |
109 | positive regulation of cation channel activity (GO:2001259) | 2.47709951 |
110 | peptide hormone secretion (GO:0030072) | 2.47343413 |
111 | vocalization behavior (GO:0071625) | 2.46986369 |
112 | relaxation of cardiac muscle (GO:0055119) | 2.46205176 |
113 | regulation of peptide secretion (GO:0002791) | 2.45633962 |
114 | regulation of autophagic vacuole assembly (GO:2000785) | 2.44694835 |
115 | negative regulation of potassium ion transport (GO:0043267) | 2.44262247 |
116 | positive regulation of heart rate (GO:0010460) | 2.42566318 |
117 | neurotransmitter biosynthetic process (GO:0042136) | 2.42500540 |
118 | actin-mediated cell contraction (GO:0070252) | 2.41439052 |
119 | glandular epithelial cell differentiation (GO:0002067) | 2.41224978 |
120 | cardiac muscle hypertrophy (GO:0003300) | 2.41115984 |
121 | peptide secretion (GO:0002790) | 2.40243783 |
122 | regulation of synaptic vesicle transport (GO:1902803) | 2.40167543 |
123 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.39911159 |
124 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.39887738 |
125 | positive regulation of amine transport (GO:0051954) | 2.38774376 |
126 | cellular ketone body metabolic process (GO:0046950) | 2.37525934 |
127 | epithelial cell fate commitment (GO:0072148) | 2.36821063 |
128 | neuron cell-cell adhesion (GO:0007158) | 2.36575850 |
129 | glycerophospholipid catabolic process (GO:0046475) | 2.36528524 |
130 | inositol phosphate catabolic process (GO:0071545) | 2.34034167 |
131 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.33020662 |
132 | long term synaptic depression (GO:0060292) | 2.30910096 |
133 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.30137819 |
134 | peroxisome fission (GO:0016559) | 2.29121101 |
135 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.24044704 |
136 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.23886020 |
137 | signal release (GO:0023061) | 2.21880946 |
138 | glycosphingolipid biosynthetic process (GO:0006688) | 2.21142810 |
139 | regulation of energy homeostasis (GO:2000505) | 2.19526492 |
140 | L-serine transport (GO:0015825) | 2.18973298 |
141 | positive regulation of glycogen metabolic process (GO:0070875) | 2.18137224 |
142 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.16903571 |
143 | regulation of vesicle fusion (GO:0031338) | 2.16498288 |
144 | synapse assembly (GO:0007416) | 2.14670579 |
145 | synaptic vesicle exocytosis (GO:0016079) | 2.12847547 |
146 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.12005325 |
147 | potassium ion export (GO:0071435) | 2.11891223 |
148 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.11171590 |
149 | positive regulation of sodium ion transport (GO:0010765) | 2.10125794 |
150 | regulation of vacuole organization (GO:0044088) | 2.08901740 |
151 | ethanol oxidation (GO:0006069) | 2.07551167 |
152 | startle response (GO:0001964) | 2.06522259 |
153 | presynaptic membrane assembly (GO:0097105) | 2.06457180 |
154 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.06215969 |
155 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.05304109 |
156 | coenzyme catabolic process (GO:0009109) | 2.04986835 |
157 | cGMP metabolic process (GO:0046068) | 2.04545615 |
158 | prostate gland growth (GO:0060736) | 2.04338600 |
159 | transcytosis (GO:0045056) | 2.03161993 |
160 | regulation of transcription involved in cell fate commitment (GO:0060850) | 2.02783893 |
161 | ketone body metabolic process (GO:1902224) | 2.02288168 |
162 | response to monoamine (GO:0071867) | 2.01320907 |
163 | response to catecholamine (GO:0071869) | 2.01320907 |
164 | calcium ion-dependent exocytosis (GO:0017156) | 2.00216472 |
165 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 1.99542821 |
166 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 1.98368402 |
167 | membrane hyperpolarization (GO:0060081) | 1.97317151 |
168 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 1.97180468 |
169 | inositol phosphate dephosphorylation (GO:0046855) | 1.97180468 |
170 | presynaptic membrane organization (GO:0097090) | 1.97016087 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.85969217 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.86116075 |
3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.38308116 |
4 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.37159886 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.34526978 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.29220814 |
7 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.26120611 |
8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22717090 |
9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.17780190 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.17623247 |
11 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.16053314 |
12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.98920814 |
13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.98222330 |
14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94720531 |
15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93529712 |
16 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.88191376 |
17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.85844846 |
18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.84886121 |
19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.84757794 |
20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.79665141 |
21 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.71746145 |
22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.67485462 |
23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.67485462 |
24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66358406 |
25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.66305682 |
26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65633003 |
27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.65503093 |
28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.65353379 |
29 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63854517 |
30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.61203394 |
31 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.49527715 |
32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43375228 |
33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.42786361 |
34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.42725131 |
35 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.36133836 |
36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36103060 |
37 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35668059 |
38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34563117 |
39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32760766 |
40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30425611 |
41 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30159043 |
42 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29537988 |
43 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29537988 |
44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.28728137 |
45 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27726509 |
46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25956796 |
47 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24861639 |
48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24581305 |
49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19696642 |
50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17644710 |
51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16111423 |
52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16024081 |
53 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15141265 |
54 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14587606 |
55 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.13663427 |
56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12552008 |
57 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12517197 |
58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11728515 |
59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11476402 |
60 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11222017 |
61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11043476 |
62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10410217 |
63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10065566 |
64 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08472764 |
65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08008984 |
66 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07082827 |
67 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06809376 |
68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06501879 |
69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04330578 |
70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04201467 |
71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04040732 |
72 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03313883 |
73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03161231 |
74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02762961 |
75 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02592132 |
76 | AR_19668381_ChIP-Seq_PC3_Human | 1.00716803 |
77 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00397675 |
78 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.99456604 |
79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98769606 |
80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98645243 |
81 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98596218 |
82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.98561573 |
83 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98352556 |
84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98127360 |
85 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97285722 |
86 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96953203 |
87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95706198 |
88 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95464119 |
89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94059086 |
90 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93900528 |
91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93407751 |
92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93274050 |
93 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.92686181 |
94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.92686181 |
95 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91212012 |
96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90538615 |
97 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90330706 |
98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89940035 |
99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89801747 |
100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89453277 |
101 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89421614 |
102 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.88648792 |
103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88324534 |
104 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87900293 |
105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87342184 |
106 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86806226 |
107 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86671237 |
108 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86293309 |
109 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85732376 |
110 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.85107555 |
111 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84976662 |
112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84819720 |
113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84760546 |
114 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.84468242 |
115 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.83936530 |
116 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83605574 |
117 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83249487 |
118 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.82605791 |
119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82461848 |
120 | FUS_26573619_Chip-Seq_HEK293_Human | 0.81916206 |
121 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81527678 |
122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81249017 |
123 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.80786129 |
124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.80625939 |
125 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.79861369 |
126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79499141 |
127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78526147 |
128 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.77890357 |
129 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.77538052 |
130 | KDM2B_26808549_Chip-Seq_REH_Human | 0.76920690 |
131 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76235671 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.37570311 |
2 | MP0000013_abnormal_adipose_tissue | 4.39653953 |
3 | MP0003646_muscle_fatigue | 3.25361521 |
4 | MP0003183_abnormal_peptide_metabolism | 3.06119125 |
5 | MP0000751_myopathy | 3.05527661 |
6 | MP0002909_abnormal_adrenal_gland | 2.92723621 |
7 | MP0004215_abnormal_myocardial_fiber | 2.73340731 |
8 | MP0004036_abnormal_muscle_relaxation | 2.62539543 |
9 | MP0004084_abnormal_cardiac_muscle | 2.62477431 |
10 | MP0005645_abnormal_hypothalamus_physiol | 2.50302023 |
11 | MP0000749_muscle_degeneration | 2.38573026 |
12 | MP0009780_abnormal_chondrocyte_physiolo | 2.31083093 |
13 | MP0000003_abnormal_adipose_tissue | 2.29690377 |
14 | MP0004043_abnormal_pH_regulation | 2.22227676 |
15 | MP0003122_maternal_imprinting | 2.11198899 |
16 | MP0004233_abnormal_muscle_weight | 1.99733243 |
17 | MP0004270_analgesia | 1.99446514 |
18 | MP0010386_abnormal_urinary_bladder | 1.96105461 |
19 | MP0003011_delayed_dark_adaptation | 1.94446272 |
20 | MP0003195_calcinosis | 1.92102030 |
21 | MP0002638_abnormal_pupillary_reflex | 1.87542904 |
22 | MP0004130_abnormal_muscle_cell | 1.85053731 |
23 | MP0000678_abnormal_parathyroid_gland | 1.84890534 |
24 | MP0002269_muscular_atrophy | 1.83662288 |
25 | MP0004145_abnormal_muscle_electrophysio | 1.80879286 |
26 | MP0001984_abnormal_olfaction | 1.80685675 |
27 | MP0005330_cardiomyopathy | 1.72738878 |
28 | MP0001944_abnormal_pancreas_morphology | 1.70012115 |
29 | MP0005379_endocrine/exocrine_gland_phen | 1.69987040 |
30 | MP0003787_abnormal_imprinting | 1.65654614 |
31 | MP0002972_abnormal_cardiac_muscle | 1.63740521 |
32 | MP0004085_abnormal_heartbeat | 1.61122126 |
33 | MP0005670_abnormal_white_adipose | 1.60989235 |
34 | MP0002234_abnormal_pharynx_morphology | 1.58796852 |
35 | MP0005620_abnormal_muscle_contractility | 1.55788758 |
36 | MP0002078_abnormal_glucose_homeostasis | 1.51860969 |
37 | MP0002106_abnormal_muscle_physiology | 1.50749523 |
38 | MP0000462_abnormal_digestive_system | 1.49253791 |
39 | MP0004087_abnormal_muscle_fiber | 1.47650573 |
40 | MP0005375_adipose_tissue_phenotype | 1.47331059 |
41 | MP0001986_abnormal_taste_sensitivity | 1.47022381 |
42 | MP0003137_abnormal_impulse_conducting | 1.46409925 |
43 | MP0005503_abnormal_tendon_morphology | 1.44600597 |
44 | MP0002102_abnormal_ear_morphology | 1.44257274 |
45 | MP0002693_abnormal_pancreas_physiology | 1.42560485 |
46 | MP0000747_muscle_weakness | 1.42125001 |
47 | MP0001501_abnormal_sleep_pattern | 1.40656267 |
48 | MP0001664_abnormal_digestion | 1.40019620 |
49 | MP0001270_distended_abdomen | 1.38971479 |
50 | MP0000750_abnormal_muscle_regeneration | 1.32234588 |
51 | MP0005369_muscle_phenotype | 1.31700768 |
52 | MP0000759_abnormal_skeletal_muscle | 1.26284187 |
53 | MP0002295_abnormal_pulmonary_circulatio | 1.24872244 |
54 | MP0003283_abnormal_digestive_organ | 1.23614603 |
55 | MP0006036_abnormal_mitochondrial_physio | 1.22590650 |
56 | MP0003635_abnormal_synaptic_transmissio | 1.21821761 |
57 | MP0006138_congestive_heart_failure | 1.20706152 |
58 | MP0010234_abnormal_vibrissa_follicle | 1.20063515 |
59 | MP0005084_abnormal_gallbladder_morpholo | 1.19404069 |
60 | MP0004859_abnormal_synaptic_plasticity | 1.17533820 |
61 | MP0001544_abnormal_cardiovascular_syste | 1.16735164 |
62 | MP0005385_cardiovascular_system_phenoty | 1.16735164 |
63 | MP0002254_reproductive_system_inflammat | 1.16263011 |
64 | MP0010329_abnormal_lipoprotein_level | 1.16041676 |
65 | MP0006072_abnormal_retinal_apoptosis | 1.14351736 |
66 | MP0000681_abnormal_thyroid_gland | 1.10406896 |
67 | MP0005551_abnormal_eye_electrophysiolog | 1.10114837 |
68 | MP0001905_abnormal_dopamine_level | 1.09168361 |
69 | MP0008961_abnormal_basal_metabolism | 1.07900282 |
70 | MP0002734_abnormal_mechanical_nocicepti | 1.05788634 |
71 | MP0000230_abnormal_systemic_arterial | 1.05352108 |
72 | MP0002877_abnormal_melanocyte_morpholog | 1.04483621 |
73 | MP0005275_abnormal_skin_tensile | 1.04361676 |
74 | MP0004484_altered_response_of | 1.03153583 |
75 | MP0002184_abnormal_innervation | 1.02819642 |
76 | MP0004019_abnormal_vitamin_homeostasis | 1.02696659 |
77 | MP0006276_abnormal_autonomic_nervous | 1.02660692 |
78 | MP0003959_abnormal_lean_body | 1.02050948 |
79 | MP0008775_abnormal_heart_ventricle | 1.01817307 |
80 | MP0005220_abnormal_exocrine_pancreas | 1.01758530 |
81 | MP0002277_abnormal_respiratory_mucosa | 1.00931357 |
82 | MP0001756_abnormal_urination | 1.00438063 |
83 | MP0001502_abnormal_circadian_rhythm | 1.00237639 |
84 | MP0002876_abnormal_thyroid_physiology | 0.99979949 |
85 | MP0003953_abnormal_hormone_level | 0.99798315 |
86 | MP0000538_abnormal_urinary_bladder | 0.99770702 |
87 | MP0001765_abnormal_ion_homeostasis | 0.98681775 |
88 | MP0001486_abnormal_startle_reflex | 0.98349608 |
89 | MP0002272_abnormal_nervous_system | 0.98176279 |
90 | MP0002063_abnormal_learning/memory/cond | 0.98147875 |
91 | MP0010368_abnormal_lymphatic_system | 0.98085819 |
92 | MP0005535_abnormal_body_temperature | 0.97099257 |
93 | MP0005187_abnormal_penis_morphology | 0.96384302 |
94 | MP0002572_abnormal_emotion/affect_behav | 0.96007790 |
95 | MP0008995_early_reproductive_senescence | 0.94377191 |
96 | MP0002163_abnormal_gland_morphology | 0.94148672 |
97 | MP0005253_abnormal_eye_physiology | 0.94101545 |
98 | MP0002139_abnormal_hepatobiliary_system | 0.93603233 |
99 | MP0001968_abnormal_touch/_nociception | 0.92767824 |
100 | MP0009745_abnormal_behavioral_response | 0.92643686 |
101 | MP0005332_abnormal_amino_acid | 0.92599661 |
102 | MP0005666_abnormal_adipose_tissue | 0.91588930 |
103 | MP0003879_abnormal_hair_cell | 0.90440178 |
104 | MP0002733_abnormal_thermal_nociception | 0.90262983 |
105 | MP0005167_abnormal_blood-brain_barrier | 0.89246115 |
106 | MP0010630_abnormal_cardiac_muscle | 0.89026646 |
107 | MP0005365_abnormal_bile_salt | 0.88495351 |
108 | MP0005646_abnormal_pituitary_gland | 0.88096702 |
109 | MP0002127_abnormal_cardiovascular_syste | 0.84838015 |
110 | MP0006292_abnormal_olfactory_placode | 0.84496585 |
111 | MP0002064_seizures | 0.84267844 |
112 | MP0004510_myositis | 0.83503970 |
113 | MP0002735_abnormal_chemical_nociception | 0.82296040 |
114 | MP0002249_abnormal_larynx_morphology | 0.82254161 |
115 | MP0002822_catalepsy | 0.80155228 |
116 | MP0002557_abnormal_social/conspecific_i | 0.79406878 |
117 | MP0003633_abnormal_nervous_system | 0.78954498 |
118 | MP0004858_abnormal_nervous_system | 0.78782690 |
119 | MP0000631_abnormal_neuroendocrine_gland | 0.77818110 |
120 | MP0001529_abnormal_vocalization | 0.76704236 |
121 | MP0008569_lethality_at_weaning | 0.75281661 |
122 | MP0002896_abnormal_bone_mineralization | 0.74937777 |
123 | MP0005448_abnormal_energy_balance | 0.74686833 |
124 | MP0004924_abnormal_behavior | 0.74666743 |
125 | MP0005386_behavior/neurological_phenoty | 0.74666743 |
126 | MP0002751_abnormal_autonomic_nervous | 0.74324676 |
127 | MP0001970_abnormal_pain_threshold | 0.72737212 |
128 | MP0002108_abnormal_muscle_morphology | 0.72235778 |
129 | MP0001188_hyperpigmentation | 0.72187656 |
130 | MP0002069_abnormal_eating/drinking_beha | 0.69916651 |
131 | MP0003880_abnormal_central_pattern | 0.68484002 |
132 | MP0002971_abnormal_brown_adipose | 0.67366193 |
133 | MP0001440_abnormal_grooming_behavior | 0.67061792 |
134 | MP0009046_muscle_twitch | 0.66647230 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.94279289 |
2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.70125076 |
3 | Ketoacidosis (HP:0001993) | 4.65019993 |
4 | Hypoglycemic coma (HP:0001325) | 4.43328072 |
5 | Sudden death (HP:0001699) | 4.25741036 |
6 | Hyperglycemia (HP:0003074) | 4.22527313 |
7 | Pheochromocytoma (HP:0002666) | 4.09047717 |
8 | Hypoglycemic seizures (HP:0002173) | 4.02440482 |
9 | Calf muscle hypertrophy (HP:0008981) | 3.83092297 |
10 | Neuroendocrine neoplasm (HP:0100634) | 3.72554035 |
11 | Exercise-induced myalgia (HP:0003738) | 3.71342650 |
12 | Myoglobinuria (HP:0002913) | 3.65186982 |
13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.59211402 |
14 | Symptomatic seizures (HP:0011145) | 3.46788582 |
15 | Late onset (HP:0003584) | 3.45951602 |
16 | Large for gestational age (HP:0001520) | 3.34129777 |
17 | Muscle fiber splitting (HP:0003555) | 3.30812994 |
18 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.29472811 |
19 | Retinal atrophy (HP:0001105) | 3.23861249 |
20 | Palpitations (HP:0001962) | 3.23722795 |
21 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.21311708 |
22 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.21311708 |
23 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.21026209 |
24 | Ventricular tachycardia (HP:0004756) | 3.20144077 |
25 | Prolonged QT interval (HP:0001657) | 3.19708353 |
26 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.17180811 |
27 | Atrial fibrillation (HP:0005110) | 3.14980429 |
28 | Ketosis (HP:0001946) | 3.04644484 |
29 | Abnormality of the calf musculature (HP:0001430) | 3.00189082 |
30 | Primary atrial arrhythmia (HP:0001692) | 2.98390579 |
31 | Syncope (HP:0001279) | 2.97770508 |
32 | Bundle branch block (HP:0011710) | 2.96195171 |
33 | Exercise-induced muscle cramps (HP:0003710) | 2.93436315 |
34 | Agitation (HP:0000713) | 2.88174891 |
35 | Supraventricular tachycardia (HP:0004755) | 2.81483473 |
36 | Enlarged penis (HP:0000040) | 2.76518072 |
37 | Congenital sensorineural hearing impairment (HP:0008527) | 2.76508515 |
38 | Supraventricular arrhythmia (HP:0005115) | 2.74843399 |
39 | Acute necrotizing encephalopathy (HP:0006965) | 2.59054322 |
40 | Asymmetric septal hypertrophy (HP:0001670) | 2.57693790 |
41 | EMG: myopathic abnormalities (HP:0003458) | 2.56214444 |
42 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.54158538 |
43 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.53876266 |
44 | Subaortic stenosis (HP:0001682) | 2.53876266 |
45 | Hyporeflexia of lower limbs (HP:0002600) | 2.51253980 |
46 | Ventricular fibrillation (HP:0001663) | 2.49200846 |
47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.45158899 |
48 | Lipoatrophy (HP:0100578) | 2.43942912 |
49 | Right ventricular cardiomyopathy (HP:0011663) | 2.42809562 |
50 | Ulnar claw (HP:0001178) | 2.42699832 |
51 | Abnormal EKG (HP:0003115) | 2.33063530 |
52 | Goiter (HP:0000853) | 2.28201256 |
53 | Myotonia (HP:0002486) | 2.26989810 |
54 | Absent speech (HP:0001344) | 2.26769399 |
55 | Dilated cardiomyopathy (HP:0001644) | 2.26225489 |
56 | Abnormality of vitamin B metabolism (HP:0004340) | 2.26209380 |
57 | Polyphagia (HP:0002591) | 2.25805978 |
58 | Neoplasm of the adrenal gland (HP:0100631) | 2.25794753 |
59 | Left ventricular hypertrophy (HP:0001712) | 2.23121073 |
60 | Acute encephalopathy (HP:0006846) | 2.21938902 |
61 | Ventricular arrhythmia (HP:0004308) | 2.21666558 |
62 | Generalized aminoaciduria (HP:0002909) | 2.17720911 |
63 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.16496941 |
64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.15083226 |
65 | Intention tremor (HP:0002080) | 2.15053533 |
66 | Methylmalonic acidemia (HP:0002912) | 2.14914307 |
67 | Hyperkalemia (HP:0002153) | 2.14610826 |
68 | Hypercortisolism (HP:0001578) | 2.14165748 |
69 | Abnormality of vitamin metabolism (HP:0100508) | 2.13852652 |
70 | Heart block (HP:0012722) | 2.13240411 |
71 | Myokymia (HP:0002411) | 2.10917884 |
72 | Anxiety (HP:0000739) | 2.10728477 |
73 | Progressive macrocephaly (HP:0004481) | 2.10360347 |
74 | Limb dystonia (HP:0002451) | 2.09858733 |
75 | Growth hormone excess (HP:0000845) | 2.09397017 |
76 | Abnormal drinking behavior (HP:0030082) | 2.09339713 |
77 | Polydipsia (HP:0001959) | 2.09339713 |
78 | Lymphangioma (HP:0100764) | 2.05222712 |
79 | Decreased circulating renin level (HP:0003351) | 2.04464311 |
80 | EEG with generalized epileptiform discharges (HP:0011198) | 2.03502608 |
81 | Epileptiform EEG discharges (HP:0011182) | 2.03497984 |
82 | Sleep apnea (HP:0010535) | 2.02451513 |
83 | Gout (HP:0001997) | 2.02317849 |
84 | Hypsarrhythmia (HP:0002521) | 2.00623757 |
85 | Oligomenorrhea (HP:0000876) | 1.99490184 |
86 | Rhabdomyolysis (HP:0003201) | 1.99293225 |
87 | Hypomagnesemia (HP:0002917) | 1.97659804 |
88 | Abnormal atrioventricular conduction (HP:0005150) | 1.96431893 |
89 | Long toe (HP:0010511) | 1.95850443 |
90 | Gait imbalance (HP:0002141) | 1.95637134 |
91 | Difficulty running (HP:0009046) | 1.95212337 |
92 | Medial flaring of the eyebrow (HP:0010747) | 1.94483931 |
93 | Menstrual irregularities (HP:0000858) | 1.93800682 |
94 | Hepatic necrosis (HP:0002605) | 1.93415486 |
95 | Neoplasm of the heart (HP:0100544) | 1.92568577 |
96 | Fetal akinesia sequence (HP:0001989) | 1.90835204 |
97 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.89499794 |
98 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.89499794 |
99 | Exocrine pancreatic insufficiency (HP:0001738) | 1.89025770 |
100 | Hyperphosphatemia (HP:0002905) | 1.88393964 |
101 | Frequent falls (HP:0002359) | 1.87797298 |
102 | Buphthalmos (HP:0000557) | 1.86865498 |
103 | Increased connective tissue (HP:0009025) | 1.86569260 |
104 | Testicular neoplasm (HP:0010788) | 1.86224443 |
105 | Abnormal eating behavior (HP:0100738) | 1.85707027 |
106 | Hyperthyroidism (HP:0000836) | 1.85230583 |
107 | Delayed CNS myelination (HP:0002188) | 1.84885423 |
108 | Depression (HP:0000716) | 1.83921780 |
109 | Hemiparesis (HP:0001269) | 1.83355403 |
110 | Hepatoblastoma (HP:0002884) | 1.83284428 |
111 | Insulin resistance (HP:0000855) | 1.83261372 |
112 | Rimmed vacuoles (HP:0003805) | 1.82963267 |
113 | Absent eyebrow (HP:0002223) | 1.82883170 |
114 | Abnormality of proline metabolism (HP:0010907) | 1.82879130 |
115 | Hydroxyprolinuria (HP:0003080) | 1.82879130 |
116 | Difficulty climbing stairs (HP:0003551) | 1.81172096 |
117 | Atrioventricular block (HP:0001678) | 1.79918926 |
118 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.79450131 |
119 | Patent foramen ovale (HP:0001655) | 1.79357213 |
120 | Hypokalemia (HP:0002900) | 1.78137788 |
121 | Broad-based gait (HP:0002136) | 1.77668000 |
122 | Mitochondrial inheritance (HP:0001427) | 1.77201939 |
123 | Muscle stiffness (HP:0003552) | 1.77070135 |
124 | Torticollis (HP:0000473) | 1.75786512 |
125 | Prominent supraorbital ridges (HP:0000336) | 1.75482611 |
126 | Bradycardia (HP:0001662) | 1.74904394 |
127 | Abnormality of potassium homeostasis (HP:0011042) | 1.74089925 |
128 | Abnormality of the renal cortex (HP:0011035) | 1.73065169 |
129 | Hypothermia (HP:0002045) | 1.72677016 |
130 | Congenital primary aphakia (HP:0007707) | 1.72420836 |
131 | Epileptic encephalopathy (HP:0200134) | 1.72174830 |
132 | Increased CSF protein (HP:0002922) | 1.71745437 |
133 | Dysdiadochokinesis (HP:0002075) | 1.71650204 |
134 | Failure to thrive in infancy (HP:0001531) | 1.71597001 |
135 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71567842 |
136 | Muscular hypotonia of the trunk (HP:0008936) | 1.71042260 |
137 | Lipid accumulation in hepatocytes (HP:0006561) | 1.69814806 |
138 | Generalized myoclonic seizures (HP:0002123) | 1.69225099 |
139 | Increased muscle lipid content (HP:0009058) | 1.69200584 |
140 | Skin nodule (HP:0200036) | 1.69000702 |
141 | Central scotoma (HP:0000603) | 1.68773801 |
142 | Abnormality of renal excretion (HP:0011036) | 1.66334611 |
143 | Increased CSF lactate (HP:0002490) | 1.66226054 |
144 | Resting tremor (HP:0002322) | 1.65640793 |
145 | Action tremor (HP:0002345) | 1.65619590 |
146 | Rectal prolapse (HP:0002035) | 1.64485841 |
147 | Hyperventilation (HP:0002883) | 1.64443606 |
148 | Limb-girdle muscle atrophy (HP:0003797) | 1.64383906 |
149 | Proximal tubulopathy (HP:0000114) | 1.64237832 |
150 | Abnormality of magnesium homeostasis (HP:0004921) | 1.64067311 |
151 | Spastic tetraplegia (HP:0002510) | 1.63774401 |
152 | Bronchomalacia (HP:0002780) | 1.63736288 |
153 | Intellectual disability, progressive (HP:0006887) | 1.62167787 |
154 | Vascular calcification (HP:0004934) | 1.61766793 |
155 | Glycosuria (HP:0003076) | 1.61001415 |
156 | Abnormality of urine glucose concentration (HP:0011016) | 1.61001415 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK3 | 6.07973318 |
2 | MAPK15 | 4.18704990 |
3 | AKT3 | 4.01654359 |
4 | FGFR2 | 2.76596169 |
5 | INSRR | 2.71893057 |
6 | TTN | 2.52189671 |
7 | PHKG2 | 2.46898441 |
8 | PHKG1 | 2.46898441 |
9 | WNK4 | 2.42912994 |
10 | STK38L | 1.99005624 |
11 | MYLK | 1.93727113 |
12 | PIK3CG | 1.86568631 |
13 | PAK3 | 1.83037109 |
14 | GRK1 | 1.79717202 |
15 | UHMK1 | 1.70897988 |
16 | PRKD3 | 1.65557225 |
17 | BRAF | 1.65316951 |
18 | LMTK2 | 1.62378583 |
19 | PDK4 | 1.59465792 |
20 | PDK3 | 1.59465792 |
21 | OBSCN | 1.59142666 |
22 | NTRK3 | 1.56126527 |
23 | CSNK1G2 | 1.53509310 |
24 | MARK1 | 1.50364031 |
25 | CSNK1G1 | 1.47096843 |
26 | SGK2 | 1.43514641 |
27 | FRK | 1.43060397 |
28 | BMPR1B | 1.42382579 |
29 | PINK1 | 1.42003765 |
30 | SGK494 | 1.40790356 |
31 | SGK223 | 1.40790356 |
32 | CSNK1G3 | 1.39779978 |
33 | BCKDK | 1.37188468 |
34 | TESK1 | 1.32107593 |
35 | KSR2 | 1.23695703 |
36 | MUSK | 1.21868184 |
37 | FER | 1.19553256 |
38 | DAPK2 | 1.16863724 |
39 | TAOK3 | 1.16223276 |
40 | MAP3K2 | 1.15287475 |
41 | EPHA3 | 1.15090169 |
42 | DMPK | 1.12428451 |
43 | CDC42BPA | 1.09839260 |
44 | SGK3 | 1.07916177 |
45 | CASK | 1.05244602 |
46 | CAMK2D | 1.02557712 |
47 | HIPK2 | 1.02123454 |
48 | CSNK1A1L | 1.00515625 |
49 | NLK | 0.99808432 |
50 | MAP3K1 | 0.99514922 |
51 | TAOK1 | 0.99125762 |
52 | MAP3K4 | 0.94878942 |
53 | SIK1 | 0.94778665 |
54 | NME1 | 0.93393602 |
55 | PRKAA2 | 0.92032868 |
56 | FGFR3 | 0.90785133 |
57 | DYRK1B | 0.89359736 |
58 | TRIB3 | 0.88711088 |
59 | STK38 | 0.87442346 |
60 | RIPK1 | 0.87188827 |
61 | MAP2K6 | 0.87070436 |
62 | DAPK1 | 0.86902963 |
63 | TIE1 | 0.86547241 |
64 | PRKCH | 0.86341174 |
65 | MAP2K1 | 0.86225927 |
66 | KSR1 | 0.85546880 |
67 | MAP3K7 | 0.84853418 |
68 | WNK1 | 0.84230956 |
69 | MAPKAPK3 | 0.83960417 |
70 | DYRK2 | 0.83517377 |
71 | TRPM7 | 0.83381411 |
72 | BCR | 0.83071161 |
73 | GRK5 | 0.83059755 |
74 | PRKG2 | 0.82911309 |
75 | PIK3CA | 0.82247771 |
76 | MAPK12 | 0.79918930 |
77 | CAMKK2 | 0.79738696 |
78 | MAP2K7 | 0.78793063 |
79 | EPHB1 | 0.78558583 |
80 | PRKD2 | 0.77886707 |
81 | NTRK1 | 0.75748338 |
82 | GRK7 | 0.74394100 |
83 | LATS1 | 0.73989096 |
84 | PRKCE | 0.73710261 |
85 | MAP4K2 | 0.73102177 |
86 | LIMK1 | 0.70954952 |
87 | PDGFRA | 0.70286633 |
88 | IRAK1 | 0.69984385 |
89 | ADRBK2 | 0.69949935 |
90 | TNK2 | 0.69469877 |
91 | SIK3 | 0.69266139 |
92 | ARAF | 0.69164318 |
93 | MAP2K4 | 0.67215336 |
94 | PRKCZ | 0.66978731 |
95 | PTK2B | 0.65852675 |
96 | STK24 | 0.64921008 |
97 | PRKAA1 | 0.64601910 |
98 | CAMK2A | 0.64332988 |
99 | PDK2 | 0.61979652 |
100 | EPHA4 | 0.61538892 |
101 | ERN1 | 0.60815059 |
102 | PRKD1 | 0.57242283 |
103 | PASK | 0.56311832 |
104 | PTK2 | 0.52514233 |
105 | SGK1 | 0.51653039 |
106 | MAP3K12 | 0.51137636 |
107 | MAP3K6 | 0.49947919 |
108 | PDPK1 | 0.49559745 |
109 | OXSR1 | 0.49231734 |
110 | PAK6 | 0.49161185 |
111 | CAMK1G | 0.48849871 |
112 | CDK5 | 0.48718043 |
113 | PRPF4B | 0.48597821 |
114 | PRKCG | 0.47858583 |
115 | PRKG1 | 0.47716522 |
116 | CAMK2B | 0.47148558 |
117 | PNCK | 0.46563019 |
118 | PRKACA | 0.45484067 |
119 | MAP3K9 | 0.44890146 |
120 | LATS2 | 0.44043996 |
121 | NTRK2 | 0.43875271 |
122 | NEK1 | 0.43680249 |
123 | CDK3 | 0.43644259 |
124 | CAMK2G | 0.42544151 |
125 | PTK6 | 0.42012919 |
126 | DYRK3 | 0.41683212 |
127 | RPS6KA2 | 0.41409292 |
128 | DAPK3 | 0.41353567 |
129 | GSK3A | 0.41255940 |
130 | STK11 | 0.40793542 |
131 | PRKACB | 0.40602722 |
132 | PKN2 | 0.40453576 |
133 | RET | 0.40437872 |
134 | PRKACG | 0.40298037 |
135 | MINK1 | 0.40228704 |
136 | CSNK1A1 | 0.39786740 |
137 | CAMK4 | 0.38981431 |
138 | TRIM28 | 0.38897001 |
139 | ROCK1 | 0.37545213 |
140 | ERBB3 | 0.36654464 |
141 | FLT3 | 0.35092486 |
142 | MARK2 | 0.34389958 |
143 | CAMK1 | 0.34077224 |
144 | DYRK1A | 0.33174814 |
145 | MAPK13 | 0.32714500 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.59268741 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.05884823 |
3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.08250904 |
4 | Insulin secretion_Homo sapiens_hsa04911 | 2.52697969 |
5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.33597305 |
6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.20217326 |
7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09163150 |
8 | Parkinsons disease_Homo sapiens_hsa05012 | 1.95711123 |
9 | Protein export_Homo sapiens_hsa03060 | 1.83686928 |
10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.79881431 |
11 | Alzheimers disease_Homo sapiens_hsa05010 | 1.73901274 |
12 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72811781 |
13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.71448811 |
14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70032154 |
15 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.63162354 |
16 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.61350537 |
17 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.56854878 |
18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.56010076 |
19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52673620 |
20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.49713400 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.49472205 |
22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46877623 |
23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43471788 |
24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.42153786 |
25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.41059411 |
26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36857818 |
27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.30394275 |
28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.28601059 |
29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.27881896 |
30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26894305 |
31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25472209 |
32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22868803 |
33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21832528 |
34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21287438 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18277894 |
36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.16594944 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13432017 |
38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.13201606 |
39 | Renin secretion_Homo sapiens_hsa04924 | 1.11459273 |
40 | Phototransduction_Homo sapiens_hsa04744 | 1.11340475 |
41 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.10518556 |
42 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.10357142 |
43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10228466 |
44 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.09875752 |
45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07543373 |
46 | Long-term potentiation_Homo sapiens_hsa04720 | 1.06139863 |
47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05588528 |
48 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03428352 |
49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.02904522 |
50 | Taste transduction_Homo sapiens_hsa04742 | 1.01304510 |
51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98867563 |
52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98198551 |
53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97060082 |
54 | Morphine addiction_Homo sapiens_hsa05032 | 0.96551797 |
55 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96395493 |
56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96104392 |
57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94085269 |
58 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92225314 |
59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90253888 |
60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89095655 |
61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88760738 |
62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87729046 |
63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86879622 |
64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86871075 |
65 | Tight junction_Homo sapiens_hsa04530 | 0.86456356 |
66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.86097722 |
67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85016220 |
68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84926984 |
69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82098351 |
70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79626051 |
71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79151964 |
72 | Prion diseases_Homo sapiens_hsa05020 | 0.77927778 |
73 | Bile secretion_Homo sapiens_hsa04976 | 0.77527894 |
74 | Nicotine addiction_Homo sapiens_hsa05033 | 0.77459091 |
75 | ABC transporters_Homo sapiens_hsa02010 | 0.77369251 |
76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75348240 |
77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75037294 |
78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74095354 |
79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73971653 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.73562147 |
81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72330790 |
82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72324109 |
83 | Long-term depression_Homo sapiens_hsa04730 | 0.70476208 |
84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69727355 |
85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69554195 |
86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69458980 |
87 | Mineral absorption_Homo sapiens_hsa04978 | 0.69290076 |
88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68799979 |
89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68407274 |
90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67841525 |
91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67795292 |
92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66863834 |
93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66074210 |
94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65661415 |
95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63979618 |
96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63383805 |
97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63059118 |
98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62328592 |
99 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62293697 |
100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61568799 |
101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59269961 |
102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57534463 |
103 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55881020 |
104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55614655 |
105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54686580 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53240896 |
107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53214167 |
108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52482809 |
109 | Salivary secretion_Homo sapiens_hsa04970 | 0.51478304 |
110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49973620 |
111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48905224 |
112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47923311 |
113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47418343 |
114 | Melanogenesis_Homo sapiens_hsa04916 | 0.47100816 |
115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46744937 |
116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46025983 |
117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45501968 |
118 | Gap junction_Homo sapiens_hsa04540 | 0.45447606 |
119 | Lysosome_Homo sapiens_hsa04142 | 0.44638393 |
120 | Lysine degradation_Homo sapiens_hsa00310 | 0.44230881 |
121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43995795 |
122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42948527 |
123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41915217 |
124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41676296 |
125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40739220 |
126 | Peroxisome_Homo sapiens_hsa04146 | 0.38061157 |
127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36568210 |
128 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36181172 |
129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34895960 |
130 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34171914 |
131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33297577 |
132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31727679 |
133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29631019 |